{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-006341","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2026-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.383866+00:00","generated_at":"2026-05-16T11:24:09.132618+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Monte Rosa Therapeutics terminates ATM stock sale program; no further sales until new prospectus filed","bullets":["Effective January 7, 2026, company terminated the ATM prospectus under its shelf registration.","No further sales of common stock under the Sales Agreement unless new prospectus filed.","As of termination date, 2,955,082 shares sold for net proceeds of $24.2 million.","Sales Agreement with Jefferies remains in effect but no sales currently authorized.","Reason for termination not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-006341","json":"https://secwatch.observer/filing/0001193125-26-006341.json","markdown":"https://secwatch.observer/filing/0001193125-26-006341.md","text":"https://secwatch.observer/filing/0001193125-26-006341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/0001193125-26-006341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/glue-20260107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:24:09.132618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}